Cited 26 time in
Evaluation of anti-diabetic activity of glycyrrhizin-loaded nanoparticles in nicotinamide-streptozotocin-induced diabetic rats
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Rani, Ruma | - |
| dc.contributor.author | Dahiya, Shakti | - |
| dc.contributor.author | Dhingra, Dinesh | - |
| dc.contributor.author | Dilbaghi, Neeraj | - |
| dc.contributor.author | Kim, Ki-Hyun | - |
| dc.contributor.author | Kumar, Sandeep | - |
| dc.date.accessioned | 2021-07-30T05:18:22Z | - |
| dc.date.available | 2021-07-30T05:18:22Z | - |
| dc.date.issued | 2017-08 | - |
| dc.identifier.issn | 0928-0987 | - |
| dc.identifier.issn | 1879-0720 | - |
| dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/4107 | - |
| dc.description.abstract | Glycyrrhizin is an active constituent of the roots and rhizomes of Glycyrrhiza glabra and has anti-hyperglycemic effects. In this study, nanoparticles (NPs) loaded with glycyrrhizin or metformin were evaluated in vivo for their anti-hyperglycemic potency towards type-II diabetes in rats. The NPs were produced via the ionotropic gelation method using the biocompatible polymers chitosan and gum arabic. The polymer concentration was optimized using the 3(2) factorial method to acquire both minimum particle size and maximum encapsulation efficiency. The NPs were then characterized with respect to particle size, encapsulation efficiency, stability, chemical interactions, and in vitro drug dissolution profiles using spectroscopic and microscopic analysis. Furthermore, glycyrrhizin and metformin and their nanoformulations were administered for 21 successive days to diabetic rats. Glycyrrhizin-loaded NPs had significant anti-diabetic effects even though they contained approximately one quarter of the dosage relative to the pure form. | - |
| dc.format.extent | 11 | - |
| dc.language | 영어 | - |
| dc.language.iso | ENG | - |
| dc.publisher | Elsevier BV | - |
| dc.title | Evaluation of anti-diabetic activity of glycyrrhizin-loaded nanoparticles in nicotinamide-streptozotocin-induced diabetic rats | - |
| dc.type | Article | - |
| dc.publisher.location | 네델란드 | - |
| dc.identifier.doi | 10.1016/j.ejps.2017.05.068 | - |
| dc.identifier.scopusid | 2-s2.0-85020395754 | - |
| dc.identifier.wosid | 000406988600024 | - |
| dc.identifier.bibliographicCitation | European Journal of Pharmaceutical Sciences, v.106, pp 220 - 230 | - |
| dc.citation.title | European Journal of Pharmaceutical Sciences | - |
| dc.citation.volume | 106 | - |
| dc.citation.startPage | 220 | - |
| dc.citation.endPage | 230 | - |
| dc.type.docType | Article | - |
| dc.description.isOpenAccess | N | - |
| dc.description.journalRegisteredClass | sci | - |
| dc.description.journalRegisteredClass | scie | - |
| dc.description.journalRegisteredClass | scopus | - |
| dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
| dc.relation.journalWebOfScienceCategory | Pharmacology & Pharmacy | - |
| dc.subject.keywordPlus | 18-BETA-GLYCYRRHETINIC ACID | - |
| dc.subject.keywordPlus | POLYMERIC NANOPARTICLES | - |
| dc.subject.keywordPlus | GLYCYRRHETINIC ACID | - |
| dc.subject.keywordPlus | METFORMIN | - |
| dc.subject.keywordPlus | MECHANISMS | - |
| dc.subject.keywordAuthor | Ionotropic gelation | - |
| dc.subject.keywordAuthor | Nanoparticles | - |
| dc.subject.keywordAuthor | Sustained release | - |
| dc.subject.keywordAuthor | Anti-diabetic effect | - |
| dc.subject.keywordAuthor | Blood glucose level | - |
| dc.subject.keywordAuthor | Lipid profile | - |
| dc.subject.keywordAuthor | Glycosylated hemoglobin | - |
| dc.identifier.url | https://www.sciencedirect.com/science/article/pii/S0928098717303202?via%3Dihub | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1366
COPYRIGHT © 2024 HANYANG UNIVERSITY.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.
